Janux Therapeutics, Inc.

JANX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 31, 2026
SCHEDULE 13G/A Jul 28, 2026
4 Jul 10, 2026
8-K Jun 23, 2026 8-K
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
4 Jun 12, 2026
8-K Jun 12, 2026 8-K
4 Jun 4, 2026
144 Jun 2, 2026
SCHEDULE 13G/A May 15, 2026
4 May 13, 2026
SCHEDULE 13G May 12, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
SCHEDULE 13G/A May 6, 2026
SCHEDULE 13G Apr 29, 2026
← Newer Page 1 of 18 · 440 filings Older →